Fundies.
English

Segment disclosures

Company overview

VERTEX PHARMACEUTICALS INC / MA

Each reported dimension combination stays separate. Revenue and operating income are shown as reported, with their dates and sources.

Revenue · Reported segment facts

1 dimension combinations 17 retained observations 12 reported periods

Counts describe retained dimensioned rows only. Periods and members can change across reports, and this view does not infer missing values or expected segment totals.

Pharmaceuticals

Statement Business Segments

Source dimensions us-gaap:StatementBusinessSegmentsAxis=vrtx:PharmaceuticalsMember
PeriodValueUnitFiledEvidence
2026-04-01 – 2026-06-303333900000 USD20260804Open filing evidence
2026-01-01 – 2026-06-306320800000 USD20260804Open filing evidence
2026-01-01 – 2026-03-312986900000 USD20260505Open filing evidence
2025-01-01 – 2025-12-3112001300000 USD20260213Open filing evidence
2025-07-01 – 2025-09-303076400000 USD20251104Open filing evidence
2025-01-01 – 2025-09-308811300000 USD20251104Open filing evidence
2025-04-01 – 2025-06-302964700000 USD20260804Open filing evidence
2025-01-01 – 2025-06-305734900000 USD20260804Open filing evidence
2025-01-01 – 2025-03-312770200000 USD20260505Open filing evidence
2024-01-01 – 2024-12-3111020100000 USD20260213Open filing evidence
2024-07-01 – 2024-09-302771900000 USD20251104Open filing evidence
2024-01-01 – 2024-09-308108100000 USD20251104Open filing evidence
2024-04-01 – 2024-06-302645600000 USD20250805Open filing evidence
2024-01-01 – 2024-06-305336200000 USD20250805Open filing evidence
2024-01-01 – 2024-03-312690600000 USD20250506Open filing evidence
2023-01-01 – 2023-12-319869200000 USD20260213Open filing evidence
2022-01-01 – 2022-12-318930700000 USD20250213Open filing evidence